However, the ACP believes that available evidence does not indicate that they should be cared for differently from men at average risk. Two trials are discussed in the statement. Patients ACP believes that all men who are considering digital rectal examination and PSA measurement should know the potential risks and benefits of screening and participate with their physicians in decision making. The benefits of one-time or repeated screening and aggressive treatment of prostate cancer have not yet been proven. The probability that further invasive evaluation will be required as a result of testing is relatively high.
Aggressive therapy is necessary to realize any benefit from the discovery of a tumor.
A small but finite risk for early death and a significant risk for chronic illness, particularly with regard to sexual and urinary function, are associated with these treatments. Early detection may save lives. Early detection and treatment may avert future cancer-related illness. L. ROSE See editorial on page 1563. Copyright 1997 by the American Academy of Family Physicians.